Cargando…

Characterisation of a Live-Attenuated Rabies Virus Expressing a Secreted scFv for the Treatment of Rabies

Rabies virus (RABV) causes possibly the oldest disease and is responsible for an estimated >59,000 human fatalities/year. Post exposure prophylaxis (PEP), the administration of vaccine and rabies immunoglobulin, is a highly effective tool which is frequently unavailable in RABV endemic areas. Fur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smith, Samuel P., Shipley, Rebecca, Drake, Pascal, Fooks, Anthony R., Ma, Julian, Banyard, Ashley C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458464/ https://www.ncbi.nlm.nih.gov/pubmed/37632016 http://dx.doi.org/10.3390/v15081674

Ejemplares similares

Generation and Characterization of an scFv Directed against Site II of Rabies Glycoprotein
por: Aavula, Shukra M., et al.
Publicado: (2011)

Bat Rabies
por: Banyard, Ashley C., et al.
Publicado: (2013)

Production and characterisation of a recombinant scFv reactive with human gastrointestinal carcinomas
por: Kim, D-J, et al.
Publicado: (2002)

Identification of Potent CD19 scFv for CAR T Cells through scFv Screening with NK/T-Cell Line
por: Kang, Chung Hyo, et al.
Publicado: (2020)

New human rabies vaccines in the pipeline
por: Fooks, Anthony R., et al.
Publicado: (2019)

scFv Antibody: Principles and Clinical Application
por: Ahmad, Zuhaida Asra, et al.
Publicado: (2012)

Taiwan Bat Lyssavirus: In Vitro and In Vivo Assessment of the Ability of Rabies Vaccine-Derived Antibodies to Neutralise a Novel Lyssavirus
por: Shipley, Rebecca, et al.
Publicado: (2022)

Reassessing the risk from rabies: A continuing threat to the UK?
por: Banyard, Ashley C., et al.
Publicado: (2010)

Nonspecificity in a nonimmune human scFv repertoire
por: Kelly, Ryan L., et al.
Publicado: (2017)

“Stapling” scFv for multispecific biotherapeutics of superior properties
por: Boucher, Lauren E., et al.
Publicado: (2023)

Assessing Rabies Vaccine Protection against a Novel Lyssavirus, Kotalahti Bat Lyssavirus
por: Shipley, Rebecca, et al.
Publicado: (2021)

Bacterial secretion of soluble and functional trivalent scFv-based N-terminal trimerbodies
por: Blanco-Toribio, Ana, et al.
Publicado: (2015)

Isolation and characterization of human anti-CD20 single-chain variable fragment (scFv) from a Naive human scFv library
por: Shams, Nasir, et al.
Publicado: (2022)

Targeting scFv-Fc-scTRAIL fusion proteins to tumor cells
por: Hutt, Meike, et al.
Publicado: (2018)

Isolation and Characterisation of a Human-Like Antibody Fragment (scFv) That Inactivates VEEV In Vitro and In Vivo
por: Rülker, Torsten, et al.
Publicado: (2012)

Current status of rabies and prospects for elimination
por: Fooks, Anthony R, et al.
Publicado: (2014)

Protein fluorescent labeling in live yeast cells using scFv-based probes
por: Tsirkas, Ioannis, et al.
Publicado: (2022)

Evolutionary History of Rabies in Ghana
por: Hayman, David T. S., et al.
Publicado: (2011)

Enhanced fluorescent imaging of proteins in live yeast cells using fluorescently labeled scFv
por: Tsirkas, Ioannis, et al.
Publicado: (2023)

The effects of N-terminal insertion into VSV-G of an scFv peptide
por: Dreja, Hanna, et al.
Publicado: (2006)

Empowering scFv with effector cell functions for improved anticancer therapeutics
por: Zhang, Hongtao
Publicado: (2013)

Integrating scFv into xMAP Assays for the Detection of Marine Toxins
por: Shriver-Lake, Lisa C., et al.
Publicado: (2016)

The Four-State Equilibrium Unfolding of a scFv Antibody Fragment
por: Pedroso, Idolka, et al.
Publicado: (2002)

Humanization and directed evolution of the selenium-containing scFv phage abzyme
por: Xu, Yan, et al.
Publicado: (2018)

Engineered Human Monoclonal scFv to Receptor Binding Domain of Ebolavirus
por: Densumite, Jaslan, et al.
Publicado: (2021)

Rabies and Distemper Outbreaks in Smallest Ethiopian Wolf Population
por: Marino, Jorgelina, et al.
Publicado: (2017)

Production of scFv-Conjugated Affinity Silk Powder by Transgenic Silkworm Technology
por: Sato, Mitsuru, et al.
Publicado: (2012)

Early Detection of NSCLC with scFv Selected against IgM Autoantibody
por: Pedchenko, Tetyana, et al.
Publicado: (2013)

Development and identification of fully human scFv-Fcs against Staphylococcus aureus
por: Nian, Siji, et al.
Publicado: (2016)

Development of Human-Like scFv-Fc Neutralizing Botulinum Neurotoxin E
por: Miethe, Sebastian, et al.
Publicado: (2015)

Targeting HER2-breast tumors with scFv-decorated bimodal nanoprobes
por: Alric, Christophe, et al.
Publicado: (2018)

Generation of a Fully Human scFv that binds Tumor-Specific Glycoforms
por: Lu, Zhongpeng, et al.
Publicado: (2019)

Characterization and analysis of scFv-IgG bispecific antibody size variants
por: Cao, Mingyan, et al.
Publicado: (2018)

Development and in vitro characterization of a humanized scFv against fungal infections
por: Di Mambro, Tomas, et al.
Publicado: (2022)

Engineering, Expression in Transgenic Plants and Characterisation of E559, a Rabies Virus-Neutralising Monoclonal Antibody
por: van Dolleweerd, Craig J., et al.
Publicado: (2014)

Rabies in Iraq: Trends in Human Cases 2001–2010 and Characterisation of Animal Rabies Strains from Baghdad
por: Horton, Daniel L., et al.
Publicado: (2013)

History of Rabies Incidence and Rabies Control in Serbia in Support of the Zero by 2030 Campaign to Eliminate Dog-Mediated Human Rabies
por: Stankov, Srđan, et al.
Publicado: (2021)

Current Rabies Vaccines Do Not Confer Protective Immunity against Divergent Lyssaviruses Circulating in Europe
por: Echevarría, Juan E., et al.
Publicado: (2019)

Relative Contribution of Framework and CDR Regions in Antibody Variable Domains to Multimerisation of Fv- and scFv-Containing Bispecific Antibodies
por: Bhatta, Pallavi, et al.
Publicado: (2018)

Bioinformatics in molecular immunology laboratories demonstrated: Modeling an anti-CMV scFv antibody
por: Heng, Chua Kek, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_r8mqr6d5nqmiqtfle5h9bh85rg